BRCA1 and neoplasm: This kind of tumours can be observed at any age; however, they mostly occur accompanied by BRCA1 mutations in younger women (>40 years of age).13 Chemotherapy is the treatment of choice for triple‐negative breast cancer patients, of which Doxorubicin and Taxol are the standard chemotherapeutic agents used as anticancer therapy in combination with α‐HER2/neu receptor targeted therapy.